ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,20
-0,82%
Dow Jones
40 211,72
0,53%
DAX
18 501,95
-0,53%
Brent Oil
83,265
-1,27%
Bitcoin
63 567,21
-1,98%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
04/11/201616h45PR Newswire (US)SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teva Pharmaceuticals Industries Limited -...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201615h59PR Newswire (US)EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Teva Pharmaceutical Industries Ltd. - TEVANYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201615h42Business WireIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Teva Pharmaceutical Industries Limited & Advises Inv...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201615h15PR Newswire (US)SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Teva Pharmaceutical Industries Limited (TEVA...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201612h00Business WireSHAREHOLDER ALERT: Investigation of Teva Pharmaceutical Announced by Holzer & Holzer, LLCNYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201612h00Dow Jones NewsBig Hit on Drug Stocks Caps $26 Billion Decline for John PaulsonNYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201608h02Dow Jones NewsGeneric Drug Firms Face Possible Collusion Charges -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201603h44Business WireIMPORTANT SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Teva Pharmaceutical Industries Limited & Advises I...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201602h12Dow Jones NewsGeneric-Drug Firms Face Possible Collusion Charges -- 1st updateNYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201600h16Business WireGlancy Prongay & Murray LLP Commences Investigation on Behalf of Teva Pharmaceuticals Investors Concerning Recent Revelations...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/11/201623h10Dow Jones NewsGeneric-Drug Makers' Shares Drop on Report of Possible ProbeNYSE:TEVATeva Pharmaceutical Industries Ltd
03/11/201621h08Dow Jones NewsDOJ Looking Into Possible Price Collusion in Generic Drug Sector -BloombergNYSE:TEVATeva Pharmaceutical Industries Ltd
02/11/201614h33Business WireCMS Establishes Unique J-Code for BENDEKA® (Bendamustine Hydrochloride) InjectionNYSE:TEVATeva Pharmaceutical Industries Ltd
02/11/201612h20Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
31/10/201613h30Business WireTeva to Report Third Quarter 2016 Financial Results on November 15, 2016NYSE:TEVATeva Pharmaceutical Industries Ltd
27/10/201602h20Dow Jones NewsAllergan CEO Brent Saunders Succeeds Paul Bisaro as ChairmanNYSE:TEVATeva Pharmaceutical Industries Ltd
26/10/201613h00PR Newswire (Canada)Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with WatsonNYSE:TEVATeva Pharmaceutical Industries Ltd
20/10/201615h00Business WireTeva Announces FDA Acceptance of Resubmitted New Drug Application for SD-809 for Treatment of Chorea Associated with Huntingt...NYSE:TEVATeva Pharmaceutical Industries Ltd
17/10/201613h00PR Newswire (US)Regeneron and Teva Provide Update on Fasinumab Clinical Development ProgramsNYSE:TEVATeva Pharmaceutical Industries Ltd
17/10/201608h00Business WireTeva Receives Positive Opinion from European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to Ex...NYSE:TEVATeva Pharmaceutical Industries Ltd
12/10/201622h07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:TEVATeva Pharmaceutical Industries Ltd
12/10/201616h00Business WireTeva Announces Launch of Generic Beyaz® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
06/10/201614h00Business WireTeva and Celltrion Announce Exclusive Biosimilar Commercial PartnershipNYSE:TEVATeva Pharmaceutical Industries Ltd
05/10/201619h10Dow Jones NewsTeva Sells Actavis Generics European Assets to Accord HealthcareNYSE:TEVATeva Pharmaceutical Industries Ltd
05/10/201617h00Business WireTeva Announces Sale of UK and Ireland Actavis Assets and OperationsNYSE:TEVATeva Pharmaceutical Industries Ltd
03/10/201615h57Business WireTeva Completes Acquisition of Anda, Inc.NYSE:TEVATeva Pharmaceutical Industries Ltd
30/09/201612h07Edgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)NYSE:TEVATeva Pharmaceutical Industries Ltd
30/09/201610h00PR Newswire (US)EU Marketing Authorization Granted for Teva's Aerivio Spiromax® (fluticasone/salmeterol 500/50)NYSE:TEVATeva Pharmaceutical Industries Ltd
29/09/201621h52Business WireTeva Announces Launch of Generic Epzicom® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
28/09/201617h01Business WireKILL Teva Announces Launch of Generic Epzicom® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NASDAQ
TETEW
Technology and Telecommu...
NASDAQ
UBXG
U BX Technology
TSXV
LITT
Right Season Investments
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés